Cortexyme, Inc. (16)

Browse by Contract Category

Contracts

Description of Securities (Filed With SEC on March 1, 2021)
Separation Agreement by and between Kristen Gafric and Cortexyme, Inc., dated as of April 27, 2020 (Filed With SEC on August 14, 2020)
Form of Stock Purchase Agreement (Filed With SEC on February 6, 2020)
Form of Indemnification Agreement between Cortexyme, Inc. and each of its officers and directors (Filed With SEC on April 29, 2019)
Second Amendment to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated May 26, 2020 (Filed With SEC on August 14, 2020)
Form of Executive Change in Control and Severance Agreement (Filed With SEC on May 21, 2020)
Description of Securities (Filed With SEC on March 16, 2020)
Amendment No. 1 to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated April 2, 2019 (Filed With SEC on August 9, 2019)
Form of Underwriting Agreement (Filed With SEC on April 29, 2019)
Specimen Stock Certificate (Filed With SEC on April 29, 2019)
2019 Equity Incentive Plan and forms of stock award agreements thereunder (Filed With SEC on April 29, 2019)
2019 Employee Stock Purchase Plan (Filed With SEC on April 29, 2019)
Amended and Restated Investors Rights Agreement by and among Cortexyme, Inc. and certain holders of its capital stock, dated May 23, 2018 (Filed With SEC on April 12, 2019)
Sub-Sublease Agreement by and between Cortexyme, Inc. and Verily Life Sciences LLC, dated June 18, 2018 (Filed With SEC on April 12, 2019)
2014 Stock Plan, as amended as of November 28, 2018, and related forms of stock award agreements (Filed With SEC on April 12, 2019)
Executive Incentive Bonus Plan (Filed With SEC on April 12, 2019)